Looking forward: where does the emerging field of genomics fit in the health care delivery system?

摘要

The field of genetics being intertwined with medical decision making is not a new phenomenon; however, novel genetic technologies and applications are bringing new decision making processes into play. The OklahomaHcalth Care Authority (OHCA) is positioning itself to deal with the emergence of biotechnology and its associated impact on diagnosis, therapeutic options, and treatment selection. The agency has placed a priority on examining and monitoring trends within the market and the effects that it will have on both the costs to administer the SoonerCare program and the quality of care available to SoonerCare members.